BiPER Therapeutics
Primary tabs
About your organization / profile
BiPER Therapeutics is a biotech company founded in 2021 to develop and commercialize novel therapeutics.
We are developing a first-in-class pipeline of small molecules overstressing cells to cure patients
BiPER ‘s name summarizes the original and unique approach of our Lead candidate targeting BiP and leading to cancer cell death through unresloved ER (Endoplasmic Reticulum) Stress induction
BiPER has an internationally recognized team of Directors and Advisors with a strong track record in Drug Discovery, Drug Development and Translational Research in Oncology associated with a solid experience in Biotech business and corporate development.
Network (0)
There are no organizations in the network.
Recent activities
BiPER Therapeutics has been awarded the Bénéficiaires French Tech Seed label.
BiPER Therapeutics has been awarded the CNRS Innovation label.
Mehdi Chelbi has joined BiPER Therapeutics.